Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model.

Autor:	Masato, Masahito1 (AUTHOR), Miyata, Yasuyoshi1 (AUTHOR) yasu-myt@nagasaki-u.ac.jp, Kurata, Hiroki1 (AUTHOR), Ito, Hidenori1 (AUTHOR), Mitsunari, Kensuke1 (AUTHOR), Asai, Akihiro1 (AUTHOR), Nakamura, Yuichiro1 (AUTHOR), Araki, Kyohei1 (AUTHOR), Mukae, Yuta1 (AUTHOR), Matsuda, Tsuyoshi1 (AUTHOR), Harada, Junki1 (AUTHOR), Matsuo, Tomohiro1 (AUTHOR), Ohba, Kojiro1 (AUTHOR), Sakai, Hideki1 (AUTHOR)
Zdroj:	Scientific Reports. 10/13/2021, Vol. 11 Issue 1, p1-7. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu